Denali Advisors LLC Corcept Therapeutics Inc Transaction History

Denali Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 09, 2018	SELL	$12.27 - $15.65 $2.77 Million - $3.53 Million	-225,600 Closed	0 $0
Q2 2018 Jul 11, 2018	SELL	$15.3 - $19.69 $315,180 - $405,614	-20,600 Reduced 8.37%	225,600 $3.55 Million
Q1 2018 Apr 23, 2018	SELL	$14.59 - $25.5 $391,012 - $683,400	-26,800 Reduced 9.82%	246,200 $4.05 Million
Q4 2017 Jan 24, 2018	BUY	$15.77 - $20.72 $4.31 Million - $5.66 Million	273,000	273,000 $4.93 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.43B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.